GlassScriptPhysician profile
Kalaivani Sivakumar
NPI 1548674583
$16,215.65
in general payments reported to CMS, 2019-2025
9 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.60 · 2020: $15K · 2021: $222 · 2022: $456 · 2023: $110 · 2024: $125 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443 · Education: $77.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.50 |
| Education | $77.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $15,000.00 | 2020 | |
| Livanova USA, INC. | $383.53 | 2022-2023 | Lifesparc |
| Abbott Laboratories | $221.69 | 2021 | |
| Bridgebio Pharma, INC. | $163.85 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $157.24 | 2022-2025 | Winrevair |
| United Therapeutics Corporation | $124.99 | 2024 | Tyvaso |
| Edwards Lifesciences Corporation | $118.04 | 2022-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $27.71 | 2025 | |
| Pfizer INC. | $18.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalaivani Sivakumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.